Labcorp Holdings Inc. L1CA34.SA Stock
Labcorp Holdings Inc. Price Chart
Labcorp Holdings Inc. L1CA34.SA Financial and Trading Overview
Labcorp Holdings Inc. stock price | 255.5 BRL |
Previous Close | 275.93 BRL |
Open | 0 BRL |
Bid | 0 BRL x N/A |
Ask | 283.5 BRL x N/A |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 341.7 BRL |
Volume | 0 BRL |
Avg. Volume | 13 BRL |
Market Cap | 97.73B BRL |
Beta (5Y Monthly) | 1.042253 |
PE Ratio (TTM) | 20.107222 |
EPS (TTM) | 6.04 BRL |
Forward Dividend & Yield | 4.6 (1.65%) |
Ex-Dividend Date | May 17, 2023 |
1y Target Est | N/A |
L1CA34.SA Valuation Measures
Enterprise Value | 30.43B BRL |
Trailing P/E | 20.107222 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.6231356 |
Price/Book (mrq) | 2.361786 |
Enterprise Value/Revenue | 2.062 |
Enterprise Value/EBITDA | 13.128 |
Trading Information
Labcorp Holdings Inc. Stock Price History
Beta (5Y Monthly) | 1.042253 |
52-Week Change | -6.12% |
S&P500 52-Week Change | 20.43% |
52 Week High | 341.7 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 278.3 BRL |
200-Day Moving Average | 296.99 BRL |
L1CA34.SA Share Statistics
Avg. Volume (3 month) | 13 BRL |
Avg. Daily Volume (10-Days) | 10 BRL |
Shares Outstanding | 354.4M |
Float | 88.3M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0.0010% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.88 |
Trailing Annual Dividend Yield | 1.04% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.2626 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.78% |
Operating Margin (ttm) | 12.03% |
Gross Margin | 27.96% |
EBITDA Margin | 15.70% |
Management Effectiveness
Return on Assets (ttm) | 5.42% |
Return on Equity (ttm) | 9.49% |
Income Statement
Revenue (ttm) | 14.76B BRL |
Revenue Per Share (ttm) | 164.13 BRL |
Quarterly Revenue Growth (yoy) | -3.10% |
Gross Profit (ttm) | 4.39B BRL |
EBITDA | 2.32B BRL |
Net Income Avi to Common (ttm) | 1B BRL |
Diluted EPS (ttm) | 13.71 |
Quarterly Earnings Growth (yoy) | -56.69% |
Balance Sheet
Total Cash (mrq) | 393.9M BRL |
Total Cash Per Share (mrq) | 4.45 BRL |
Total Debt (mrq) | 6.36B BRL |
Total Debt/Equity (mrq) | 61.37 BRL |
Current Ratio (mrq) | 1.627 |
Book Value Per Share (mrq) | 116.721 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.72B BRL |
Levered Free Cash Flow (ttm) | 970.19M BRL |
Profile of Labcorp Holdings Inc.
Country | Brazil |
State | NC |
City | Burlington |
Address | 358 South Main Street |
ZIP | 27215 |
Phone | 336 229 1127 |
Website | https://www.labcorp.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 80000 |
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Q&A For Labcorp Holdings Inc. Stock
What is a current L1CA34.SA stock price?
Labcorp Holdings Inc. L1CA34.SA stock price today per share is 255.5 BRL.
How to purchase Labcorp Holdings Inc. stock?
You can buy L1CA34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Labcorp Holdings Inc.?
The stock symbol or ticker of Labcorp Holdings Inc. is L1CA34.SA.
Which industry does the Labcorp Holdings Inc. company belong to?
The Labcorp Holdings Inc. industry is Diagnostics & Research.
How many shares does Labcorp Holdings Inc. have in circulation?
The max supply of Labcorp Holdings Inc. shares is 337.17M.
What is Labcorp Holdings Inc. Price to Earnings Ratio (PE Ratio)?
Labcorp Holdings Inc. PE Ratio is 42.30132300 now.
What was Labcorp Holdings Inc. earnings per share over the trailing 12 months (TTM)?
Labcorp Holdings Inc. EPS is 6.04 BRL over the trailing 12 months.
Which sector does the Labcorp Holdings Inc. company belong to?
The Labcorp Holdings Inc. sector is Healthcare.